Navigation Links
NHS to fund Herceptin treatment for Stuart weaver

Herceptin is one of a new generation drug that can treat breast cancer. But NHS said that it would fund the treatment for patients suffering from later stages of breast cancer. // Due to this there are lots of legal challenges by cancer sufferers to force their local health care providers to pay for the drug. The latest being a British man, Stuart Weaver who filed the case and won it. He was told that his local NHS trust would fund for his treatment with Herceptin. Maidstone Weald Primary Care Trust said that they have agreed only after reviewing his age, clinical needs and advice from his medical consultants.

He is 37 years old and is suffering from breast cancer. Herceptin has created lot of commotion as it attacks only cancer cells and does not pose a lot of damage to the normal ones. It is also much better than the traditional chemotherapy. Herceptin is manufactured by Switzerland's Roche and is very expensive. It costs about $37,168 a year and is licensed only for patients suffering with advanced breast cancer. But doctors can prescribe it to those patients who they feel should receive the drug for treatment. Although it is shown that Herceptin can help patients in the early stages of breast cancer health authorities respond negatively for funding the treatment in early stage breast cancer except for exceptional cases.


'"/>




Page: 1

Related medicine news :

1. Nurse wins her case over use of Herceptin for her Breast cancer
2. Drug Herceptin To Be Recommended To All Breast Cancer Patients
3. Herceptin Is A Possible Cure For Breast Cancer
4. Herceptin Not A ‘Wonder’ Drug, Says The Lanct
5. £6000 to be refunded to Mrs. Leese for Herceptin treatmen
6. Wangaratta Community fundraising for Herceptin drug
7. Herceptin for Early Stage Breast cancer
8. Treatment of Breast Cancer with Herceptin for Nine Weeks
9. Herceptin is the cure for early stages of breast cancer?
10. 10-year-old Pleads, Herceptin For My Mum, Please
11. Norfolk PCTs To Offer Herceptin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/30/2016)... ... 30, 2016 , ... Dr. Trevor Gardner, President of the ... a multifaceted agreement which will allow for the research and development of medical ... and Applied Sciences, Allied Health and Nursing will work together to develop new ...
(Date:4/29/2016)... Dobbs Ferry, New York (PRWEB) , ... April 30, 2016 , ... ... and the Dobbs Ferry campus. The following programs will be expanding due to ... Resources Management (HRM). The expansion will begin this summer. , School ...
(Date:4/29/2016)... ... ... Our bodies are bombarded daily by environmental and lifestyle factors that can ... to adopt a more healthful diet, but too many people think that food has ... and the creator of the Newport Beach Cleanse and 14-Day Eating Plan, disagrees whole-heartedly. ...
(Date:4/29/2016)... ... April 29, 2016 , ... Conditions were ideal for Global Lyme Alliance’s (GLA) ... with sunny skies, a light breeze and temperatures in the 60s. Over 400 runners, ... Run and Walk and 1-mile walk were held to increase awareness about Lyme ...
(Date:4/29/2016)... ... April 29, 2016 , ... Mobility Designed is redefining mobility with ... armpits, the M+D Crutch evenly distributes body weight from the elbow to the forearm. ... using the crutches than with other crutches. , Co-founders Max and Liliana Younger were ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016  While Abbott,s announced ... the company,s valve repair and stent business, healthcare ... places Abbott more firmly into patient monitoring.  Kalorama ... fastest growing device areas, with double-digit growth expected ... report,  Advanced Remote Patient Monitoring . ...
(Date:4/28/2016)... , April 28, 2016 ... , George Phillips und ... Unternehmens    ArisGlobal®, ein führender ... Sciences, gab heute bekannt, dass neue Führungskräfte ... Unternehmens gestoßen sind, die vielfältige Erfahrungen mitbringen. ...
(Date:4/28/2016)... Ind., April 28, 2016 , Net Sales ... reported basis over the prior year period, and an increase ... , Diluted EPS for the first quarter were $0.52 ... and $2.00 adjusted, an increase of 29.9% over the prior ... and adjusted earnings guidance for 2016 Zimmer Biomet ...
Breaking Medicine Technology: